CI
INDP icon

Cowen Inc’s Indaptus Therapeutics INDP Stock Holding History

Cowen Inc’s Portfolio INDP Stock Details INDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$20K Buy
+2
New +$25.2K ﹤0.01% 381

Other funds holding INDP

MIH
Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

Cowen Inc's INDP Position: Q2 2019 in Review

Cowen Inc opened a new position in Indaptus Therapeutics (INDP) in Q2 2019: 2 shares worth $20K. The stake represents ﹤0.01% of the portfolio and ranks #381 among its holdings.

47 funds tracked by Wall St. Rank hold INDP as of Q2 2019.

  • Cowen Inc held 2 shares of Indaptus Therapeutics worth $20K as of Q2 2019.
  • Indaptus Therapeutics was a new Cowen Inc position in Q2 2019.
  • Indaptus Therapeutics made up ﹤0.01% of Cowen Inc's portfolio in Q2 2019, its #381 holding.
  • 47 funds tracked by Wall St. Rank held Indaptus Therapeutics as of Q2 2019.

Based on Cowen Inc's 13F filing for Q2 2019, filed 14 Aug 2019.